Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
Braz J Med Biol Res ; 48(5): 458-64, 2015 May.
Article in English | MEDLINE | ID: mdl-25760030

ABSTRACT

Esophageal atresia (EA) is characterized by esophageal and gastric motility changes secondary to developmental and postsurgical damage. This study evaluated the in vitro contractile profile of the distal esophagus and gastric fundus in an experimental model of EA induced by doxorubicin (DOXO). Wistar pregnant rats received DOXO 2.2 mg/kg on the 8th and 9th gestational days. On day 21.5, fetuses were collected, sacrificed, and divided into groups: control, DOXO without EA (DOXO-EA), and DOXO with EA (DOXO+EA). Strips from the distal esophagus and gastric fundus were mounted on a wire myograph and isolated organ-bath system, respectively, and subjected to increasing concentrations of carbamylcholine chloride (carbachol, CCh). The isolated esophagus was also stimulated with increasing concentrations of KCl. In esophagus, the concentration-effect curves were reduced in response to CCh in the DOXO+EA and DOXO-EA groups compared to the control group (P<0.05). The maximum effect values (Emax) for DOXO+EA and DOXO-EA were significantly lower than control (P<0.05), but the half-maximal effective concentration (EC50) values were not significantly different when the three groups were compared (P>0.05). In response to KCl, the distal esophagus samples in the three groups were not statistically different with regard to Emax or EC50 values (P>0.05). No significant difference was noted for EC50 or Emax values in fundic strips stimulated with CCh (P>0.05). In conclusion, exposure of dams to DOXO during gestation inhibited the contractile behavior of esophageal strips from offspring in response to CCh but not KCl, regardless of EA induction. The gastric fundus of DOXO-exposed offspring did not have altered contractile responsiveness to cholinergic stimulation.


Subject(s)
Esophageal Atresia/physiopathology , Esophagus/physiopathology , Gastric Fundus/physiopathology , Muscle Contraction/physiology , Tracheoesophageal Fistula/diagnosis , Animals , Antibiotics, Antineoplastic , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Disease Models, Animal , Doxorubicin , Esophageal Atresia/chemically induced , Female , Fetus , Gastric Fundus/drug effects , In Vitro Techniques , Myography , Pregnancy , Rats, Wistar
2.
Obes Surg ; 22(12): 1874-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22915063

ABSTRACT

BACKGROUND: Bariatric surgery is the most effective treatment for gastro-esophageal reflux disease (GERD) in obese patients, with the Roux-en-Y gastric bypass being the technique preferred by many surgeons. Published data reporting the results of laparoscopic sleeve gastrectomy (LSG) in patients with GERD are contradictory. In a previous observational study, we found that relative narrowing of the distal sleeve, hiatal hernia (HH), and dilation of the fundus predispose to GERD after LSG. In this study, we evaluated the effects of standardization of our LSG technique on the incidence of postoperative symptoms of GERD. METHODS: This was a concurrent cohort study. Patients who underwent bariatric surgery at our center were followed prospectively. LSG was performed in all patients in this series. RESULTS: A total of 234 patients underwent surgery. There were no cases of death, fistula, or conversion to open surgery. All 134 patients who completed 6-12 months of postoperative follow-up were evaluated. Excess weight loss at 1 year was 73.5%. In the study group, 66 patients (49.2%) were diagnosed with GERD preoperatively, and HH was detected in 34 patients (25.3%) intraoperatively. HH was treated by reduction in three patients, anterior repair in 28, and posterior repair in three. Only two patients (1.5%) had symptoms of GERD at 6-12 months postoperatively. CONCLUSIONS: Our results confirm that careful attention to surgical technique can result in significantly reduced occurrence of symptoms of GERD up to 12 months postoperatively, compared with previous reports of LSG in the literature.


Subject(s)
Gastric Fundus/surgery , Gastroesophageal Reflux/surgery , Gastroplasty , Hernia, Hiatal/surgery , Obesity, Morbid/surgery , Adult , Body Mass Index , Female , Follow-Up Studies , Gastric Fundus/physiopathology , Gastroesophageal Reflux/physiopathology , Hernia, Hiatal/physiopathology , Humans , Laparoscopy , Male , Middle Aged , Obesity, Morbid/complications , Obesity, Morbid/physiopathology , Postoperative Period , Prospective Studies , Treatment Outcome , Weight Loss
3.
Hepatogastroenterology ; 50(49): 102-6, 2003.
Article in English | MEDLINE | ID: mdl-12630002

ABSTRACT

BACKGROUND/AIMS: After variceal eradication by endoscopic ligation, fundal varices and worsening of portal hypertensive gastropathy can occur. The aim of this study is to verify the impact of the eradication of esophageal varices by endoscopic ligation on the portal pressure gradient, worsening of portal hypertensive gastropathy and development of fundal varices. METHODOLOGY: Twenty-two (15M/7F, mean age: 54.5 years) cirrhotics with previous variceal bleeding were submitted to measurement of hepatic venous pressure gradient before and after variceal eradication by endoscopic ligation. RESULTS: The mean hepatic venous pressure gradient in the first measurement was 14.1 mmHg and after eradication, 13.5 mmHg (p = 0.403). After eradication, 12 patients experienced a reduction in portal pressure and 10, an elevation. Three patients developed fundal varices. Their mean gradient before treatment was 22 mmHg and 18.8 mmHg after therapy (p = 0.368). The gastropathy worsened in 9 patients (mean gradient before therapy of 15.2 mmHg; and 16.1 mmHg after treatment) (p = 0.303). The initial pressure gradient of these patients was not different from the other 13 cases (p = 0.463). CONCLUSIONS: The esophageal variceal eradication by endoscopic band ligation does not alter the hepatic venous pressure gradient. There is no significant variation in the portal pressure of patients in whom there was a worsening of portal hypertensive gastropathy or fundal varices development.


Subject(s)
Endoscopy/adverse effects , Esophageal and Gastric Varices/etiology , Esophageal and Gastric Varices/surgery , Gastric Fundus/surgery , Hypertension, Portal/etiology , Liver Cirrhosis/surgery , Postoperative Complications , Adult , Aged , Esophageal and Gastric Varices/physiopathology , Female , Gastric Fundus/physiopathology , Humans , Hypertension, Portal/physiopathology , Ligation/adverse effects , Liver Cirrhosis/physiopathology , Male , Middle Aged , Portal Pressure/physiology , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL